{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:11:17Z","timestamp":1788631877612,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.chest.2023.12.013","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T22:09:45Z","timestamp":1702591785000},"page":"1247-1259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy"],"prefix":"10.1016","volume":"165","author":[{"given":"Hunter C.","family":"Gits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra A.","family":"Khosravi Flanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie D.","family":"Kapplinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani S.","family":"Reisenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Eiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8039-2398","authenticated-orcid":false,"given":"William G.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9777-5202","authenticated-orcid":false,"given":"Linh H.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney N.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda I.","family":"Garces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Hallemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Merrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Schild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. John","family":"Lucido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Robert","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Cassivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanda","family":"Blackmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Tapias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Callstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2023.12.013_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2006.01.006","article-title":"Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial","volume":"52","author":"Brodowicz","year":"2006","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.chest.2023.12.013_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(10)70112-1","article-title":"Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study","volume":"11","author":"Cappuzzo","year":"2010","journal-title":"Lancet Oncol"},{"issue":"9699","key":"10.1016\/j.chest.2023.12.013_bib3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(09)61497-5","article-title":"Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study","volume":"374","author":"Ciuleanu","year":"2009","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.chest.2023.12.013_bib4","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2012.47.1102","article-title":"PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer","volume":"31","author":"Paz-Ares","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.chest.2023.12.013_bib5","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.chest.2023.12.013_bib6","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.chest.2023.12.013_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): extended long-term outcomes","volume":"15","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10185","key":"10.1016\/j.chest.2023.12.013_bib8","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.chest.2023.12.013_bib9","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.chest.2023.12.013_bib10","doi-asserted-by":"crossref","first-page":"djx015","DOI":"10.1093\/jnci\/djx015","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial","volume":"109","author":"Ruers","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.chest.2023.12.013_bib11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.chest.2023.12.013_bib12","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1158\/1078-0432.CCR-04-2062","article-title":"Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer","volume":"11","author":"Gulley","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"7547","key":"10.1016\/j.chest.2023.12.013_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature14347","article-title":"The evolutionary history of lethal metastatic prostate cancer","volume":"520","author":"Gundem","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.chest.2023.12.013_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.adro.2017.08.003","article-title":"Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancer","volume":"2","author":"Gustafson","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.chest.2023.12.013_bib15","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1038\/ncomms7605","article-title":"Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer","volume":"6","author":"Hong","year":"2015","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.chest.2023.12.013_bib16","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumor self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.chest.2023.12.013_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.chest.2023.12.013_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/02841860802662722","article-title":"Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis","volume":"48","author":"Rusthoven","year":"2009","journal-title":"Acta Oncol"},{"issue":"23","key":"10.1016\/j.chest.2023.12.013_bib19","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.1158\/1078-0432.CCR-21-2510","article-title":"Phase II evaluation of stereotactic ablative radiotherapy (SABR) and immunity in (11)C-Choline-PET\/CT-identified oligometastatic castration-resistant prostate cancer","volume":"27","author":"Zhang","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.chest.2023.12.013_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.clon.2019.05.015","article-title":"The dandelion dilemma revisited for oligoprogression: Treat the whole lawn or weed selectively?","volume":"31","author":"Patel","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"10.1016\/j.chest.2023.12.013_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.chest.2023.12.013_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of Observation vs\u00a0Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.chest.2023.12.013_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.athoracsur.2014.05.023","article-title":"The prognosis of pulmonary metastasectomy depends on the location of the primary colorectal cancer","volume":"98","author":"Cho","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.chest.2023.12.013_bib24","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","article-title":"Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols","volume":"21","author":"Kager","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.chest.2023.12.013_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases","volume":"113","author":"Pastorino","year":"1997","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.chest.2023.12.013_bib26","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.athoracsur.2014.05.048","article-title":"Lung metastases from colorectal cancer: analysis of prognostic factors in a single institution study","volume":"98","author":"Zampino","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.chest.2023.12.013_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MCP.0b013e328300cabe","article-title":"Sublobar resection in nonsmall cell lung carcinoma","volume":"14","author":"Bilfinger","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.chest.2023.12.013_bib28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamaoncol.2021.0687","article-title":"Evaluation of safety of stereotactic body radiotherapy for the treatment of patients with multiple metastases: findings from the NRG-BR001 phase 1 trial","volume":"7","author":"Chmura","year":"2021","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.chest.2023.12.013_bib29","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"26","key":"10.1016\/j.chest.2023.12.013_bib30","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1200\/JCO.2014.55.4675","article-title":"Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice","volume":"32","author":"Timmerman","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.chest.2023.12.013_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1748-717X-9-91","article-title":"Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments","volume":"9","author":"Navarria","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.chest.2023.12.013_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2016.04.012","article-title":"Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-a pooled analysis of the German working group \"stereotactic radiotherapy\"","volume":"97","author":"Rieber","year":"2016","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.chest.2023.12.013_bib33","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/annonc\/mdq098","article-title":"Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients","volume":"21","author":"Chua","year":"2010","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.chest.2023.12.013_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10147-018-1357-5","article-title":"CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer","volume":"24","author":"Hiyoshi","year":"2019","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.chest.2023.12.013_bib35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jvir.2006.11.003","article-title":"Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan","volume":"18","author":"Yamakado","year":"2007","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"7","key":"10.1016\/j.chest.2023.12.013_bib36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2020.02.022","article-title":"Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE)","volume":"15","author":"Callstrom","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"10","key":"10.1016\/j.chest.2023.12.013_bib37","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/JTO.0000000000000632","article-title":"Evaluating cryoablation of metastatic lung tumors in patients--safety and efficacy: the ECLIPSE trial--interim analysis at 1 year","volume":"10","author":"de Baere","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"11","key":"10.1016\/j.chest.2023.12.013_bib38","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jtho.2021.07.021","article-title":"The ECLIPSE study: efficacy of cryoablation on metastatic lung tumors with a 5-year follow-up","volume":"16","author":"de Baere","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.chest.2023.12.013_bib39","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ijrobp.2016.04.016","article-title":"Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy in inoperable stage I non-small cell lung cancer: a systemic review and pooled analysis","volume":"95","author":"Bi","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.chest.2023.12.013_bib40","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.chest.2023.12.013_bib41","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jvir.2019.11.035","article-title":"Survival outcomes of treatment with radiofrequency ablation, stereotactic body radiotherapy, or sublobar resection for patients with clinical stage I non-small-cell lung cancer: a single-center evaluation","volume":"31","author":"Iguchi","year":"2020","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"6","key":"10.1016\/j.chest.2023.12.013_bib42","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.21037\/jtd-21-1826","article-title":"A\u00a0guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation","volume":"14","author":"Park","year":"2022","journal-title":"J\u00a0Thorac Dis"},{"issue":"5","key":"10.1016\/j.chest.2023.12.013_bib43","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2012.07.2354","article-title":"Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly","volume":"84","author":"Shirvani","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.chest.2023.12.013_bib44","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jvir.2021.02.025","article-title":"Effectiveness of thermal ablation and stereotactic radiotherapy based on stage I lung cancer histology","volume":"32","author":"Uhlig","year":"2021","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"12","key":"10.1016\/j.chest.2023.12.013_bib45","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1513\/AnnalsATS.202203-275OC","article-title":"Adverse events following limited resection versus stereotactic body radiation therapy for early-stage lung cancer","volume":"19","author":"Wang","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"740","key":"10.1016\/j.chest.2023.12.013_bib46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"issue":"991","key":"10.1016\/j.chest.2023.12.013_bib47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1259\/bjr\/31372149","article-title":"21 years of biologically effective dose","volume":"83","author":"Fowler","year":"2010","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.chest.2023.12.013_bib48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","article-title":"An application of changepoint methods in studying the effect of age on survival in breast cancer","volume":"30","author":"Contal","year":"1999","journal-title":"Computational Statistics & Data Analysis"},{"issue":"3","key":"10.1016\/j.chest.2023.12.013_bib49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.radonc.2013.05.024","article-title":"Pulmonary oligometastases: Metastasectomy or stereotactic ablative radiotherapy?","volume":"107","author":"Widder","year":"2013","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.chest.2023.12.013_bib50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clon.2016.02.001","article-title":"Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer","volume":"28","author":"Filippi","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"12","key":"10.1016\/j.chest.2023.12.013_bib51","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/1759-7714.12880","article-title":"Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases","volume":"9","author":"Lee","year":"2018","journal-title":"Thorac Cancer"},{"issue":"1","key":"10.1016\/j.chest.2023.12.013_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diii.2020.09.006","article-title":"Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease","volume":"102","author":"Tselikas","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.chest.2023.12.013_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.critrevonc.2018.06.005","article-title":"Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: systematic review","volume":"129","author":"Kobiela","year":"2018","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223058531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223058531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:59:13Z","timestamp":1717592353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369223058531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0012369223058531"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2023.12.013","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2023.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}